Gedeon Richter PLC (RICHTER GEDEON VEGYESZETI GYAR ) Aktie

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women's healthcare, cardiovascular, and central nervous system. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and aesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, an emergency contraceptive pill; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound care; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergy; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat and local anesthetic. Further, it provides financial and accounting, social and welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.